Not exact matches
Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and
diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in
Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual
Report on Form 10 - K and our subsequently filed Quarterly
Reports on Form 10 - Q.
Those that did make this
diagnostic distinction
reported recommending environmental
management and prescribing medication significantly more often that those that did not make this distinction.
The mortality rate of canine influenza has been
reported to range from 1 % to 8 % in puppies and older dogs.2 Serology can be performed to confirm a diagnosis of CIV infection; however, samples must be sent out, so this
diagnostic test does not help acute
management.8
Patents U.S. Patent 5,196,311 ELISA Test for von Willebrand Factor U.S. Patent 5,202,264 ELISA Using Multi-Species Antibodies for Detection of von Willebrand Factor in Multiple Species U.S. Patent 5,486,685 Oven with Food Presence Indicator U.S. Patent 5,830,709 Detection Method for Homologous Portions of a Class of Substances U.S. Patent 6,287,254 Animal Health Diagnostics U.S. Patent 6,537,213 Animal Health Care, Well - Being and Nutrition U.S. Patent 6,730,023 Animal Genetic and Health Profile Database
Management U.S. Patent 7,029,441 Animal Health Care, Well - Being and Nutrition U.S. Patent 7,134,995 Animal Genetic and Health Profile Database
Management U.S. Patent 7,548,839 System for Animal Health Diagnostics U.S. Patent 7,552,039 Method for Sample Processing and Integrated
Reporting of Dog Health Diagnosis U.S. Patent 7,794,954 Detection and Measurement of Thyroid Analyte Profile U.S. Patent 7,797,145 Animal Health Diagnostics U.S. Patent 7,799,532 Detection and Measurement of Thyroid Hormone Autoantibodies U.S. Patent 7,865,343 A Method of Analyzing Nutrition for a Canine or Feline Animal U.S. Patent 7,867,720 Food Sensitivity Testing in Animals U.S. Patent 7,873,482
Diagnostic System for Selecting Nutrition and Pharmacological Products for Animals U.S. Patent 8,060, 354 System and Method for Determining a Nutritional Diet for a Canine or Feline Animal
October 8, 2005 Sunnyvale, CA An Advanced Course:
Management of the Ferret for Veterinary Professionals SESSION I: Emergency Medicine & Critical Care — N. Antinoff SESSION II: Oncology General Oncology Overview and Tips for Treating Ferrets with Cancer - N. Antinoff Lymphoma: A retrospective review of disease,
diagnostics, and treatment — N. Antinoff A new lymphoma chemotherapy protocol for ferrets — Preliminary observations - J. Mayer SESSION III: Gastrointestinal & Hepatic Diseases — M. Burgess SESSION IV: Studying Ferret Behavior — V. Staton SESSION V: Disseminated Idiopathic Myositis — An Emerging Disease — K. Ramsell CASE
REPORTS — R. Gandolfi / A.
Guy Constant and commercial partner Gayle Curry advised InHealth Group on buying shares in Health Intelligence and Pain
Management Solutions, acquiring RIG
Reporting from RIG Healthcare Recruit, and purchasing Care UK's
diagnostics and clinical assessment and treatment services in the North West.
Primary areas of focus for AG Consulting in recent months have included: the development of
diagnostic tools for team effectiveness; legal department benchmarking; legal department strategy and operating models; legal technology; data,
management information and
reporting; legal process analysis; and spend analytics.
When you make an appointment at the Apple Store, Genius Bar employees will run a
diagnostic on your iPhone to see if the battery is below its operational threshold; that said, we've seen multiple
reports and received independent confirmation that if the part is in stock, the Genius will replace it for you even if your existing battery is still powerful enough to avoid Apple's power
management program.
Patient - focused and compassionate caregiver.LicensesRegistered Nurse, State of California, 2003 - Present First Aid, CPR, and ACLS CertificationsSkill HighlightsMedication administration expert Committed to compliance
reporting Diagnostic tools experience Culturally sensitive Skilled in conducting physical examinations and assessmentsACLS instructor Geriatric treatment knowledge Strong medical and work ethics Computerized charting specialist Familiarity with disease
management programsProfessional ExperienceAugust 2008 to Current Savoy General Hospital New Cityland, CA Intensive Care Unit Registered NurseProvide exceptional care to critically ill patients in ICU.
Tags for this Online Resume: Biotechnology,
Diagnostic, Pharmaceutical, Marketing, Oncology, Strategy, Brand Planning, Global Marketing, New Product Planning, Pricing, Market Research, Brand Leader, Commercial, Commercialization, Launch, Drug Development, Matrix, Cross Functional, Digital, KOL, Key Opinion Leader, Portfolio,
Management, Brand Team, Agency, Diabetes, Cardiovascular, Commercial Strategy, Corporate Affairs, Communications, Hematology, Urology, Neuroscience, phase 2, phase 3, phase II, phase III, Powerpoint, Excel, Word, Part B, Part D, Seattle, Portland, San Francisco, Executive Director, Senior Director, Director, Vice President, Go - To - Market, Value Proposition, Go To Market, Launch Planning, Access, Reimbursement, Payer, Market Development, Market Assessment, Pipeline, In - Line, Brand
Management, Coaching, Leadership, Marketing Strategies, Marketing Strategy, Strategic Planning, Autoimmune, Early Stage, Pre-Launch, Pre Launch, Regulatory, Operations, Marketing Plan, Business Plan, Business Development, Market Analysis, Segmentation, Targeting, Companion
Diagnostic, Target Product Profile, Pre-Clinical, Competition, Positoning, Branding, Sales, Budget, Sales
Management, Communication Plan, Publication Plan, Project
Management, Genetic, Genomic, Lifecycle, Long Range, Device, Late Stage, Direct
Report, Indirect
Report, New Molecular Entities, Competitive, Biopharmaceutical, Medical Device, Non-Promotional, Tactical, Execution, IND, Revenue, Partner, Clinical, Consult, Analytical, Problem Solver, Global, International, Affordable Care Act, Lymphoma, Leukemia, Prostate, Breast, Cancer, OPDP, Promotional, Promotions, Brand, Healthcare, Distribution, Infrastructure, IMS, Priority Review, Experienced, Patient, Consumer
Tags for this Online Resume: Validation, CAPA investigations, FDA regulated devices, Product Development, FMECA, Manager, Failure Investigations, Data analysis, Plan /
Report writing, Process Excellence, Project
Management, Policy Development, Procedure Development, Medical
Diagnostic Devices